Increased blood glucose level following hysterectomy among reproductive women in India

The Role of Estrogen across Multiple Disease Mechanisms

Estrogen is a significant hormone that is involved in a multitude of physiological and pathological processes. In addition to its pivotal role in the reproductive system, estrogen is also implicated in the pathogenesis of a multitude of diseases. Nevertheless, previous research on the role of estrogen in a multitude of diseases, including Alzheimer's disease, depression, cardiovascular disease, diabetes, osteoporosis, gastrointestinal diseases, and estrogen-dependent cancers, has concentrated on a single disease area, resulting in a lack of comprehensive understanding of cross-disease mechanisms. This has brought some challenges to the current treatment methods for these diseases, because estrogen as a potential therapeutic tool has not yet fully developed its potential. Therefore, this review aims to comprehensively explore the mechanism of estrogen in these seven types of diseases. The objective of this study is to describe the relationship between each disease and estrogen, including the ways in which estrogen participates in regulating disease mechanisms, and to outline the efficacy of estrogen in treating these diseases in clinical practice. By studying the role of estrogen in a variety of disease mechanisms, it is hoped that a more accurate theoretical basis and clinical guidance for future treatment strategies will be provided, thus promoting the effective management and treatment of these diseases.

Effect of Reflexology on Decreasing Postoperative Pain and Anxiety After Total Abdominal Hysterectomy

Surgical patients experience both postoperative pain and anxiety, as they try to cope with pain. Despite technological advances, pharmacological methods are inadequate for decreasing postoperative pain and anxiety. Reflexology has been implemented and considered effective in these areas in many countries. The aim of this study was to determine the effect of reflexology on decreasing postoperative pain and anxiety after a hysterectomy. The study was an intervention randomized study. The population of the investigation is all patients who had a hysterectomy between February 2012 and December 2014 in the Istanbul University Obstetrics and Gynecology service. The sample was 100 women chosen after a power analysis (minimum: 74) (experimental: 54, control: 46) within the population of the investigation who agreed to participate in the study. Using a table of random numbers, patients in the sample were divided into groups. Data was collected using the patient information and vital signs form, State-Trait Anxiety Inventory (STAI-I), Visual Analog Scale (VAS) Pain and Anxiety Scales, and BRIEF pain inventory. All women in the groups had similar sociodemographic, obstetric, and pain characteristics, past experience of illness, and characteristics related to their hysterectomy. All of the patients in the reflexology group stated that reflexology helped them feel better. The reflexology group compared with the control group had lower than the average VAS pain and VAS and STAI anxiety at all assessment times. Reflexology is effective in reducing anxiety and pain.

Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases

Metabolic diseases, such as obesity, metabolic syndrome (MetS) and type 2 diabetes (T2D), are now a widespread pandemic in the developed world. These pathologies show sex differences in their development and prevalence, and sex steroids, mainly estrogen and testosterone, are thought to play a prominent role in this sexual dimorphism. The influence of sex hormones on these pathologies is not only reflected in differences between men and women, but also between women themselves, depending on the hormonal changes associated with the menopause. The observed sex differences in gut microbiota composition have led to multiple studies highlighting the interaction between steroid hormones and the gut microbiota and its influence on metabolic diseases, ultimately pointing to a new therapy for these diseases based on the manipulation of the gut microbiota. This review aims to shed light on the role of sexual hormones in sex differences in the development and prevalence of metabolic diseases, focusing on obesity, MetS and T2D. We focus also the interaction between sex hormones and the gut microbiota, and in particular the role of microbiota in aspects such as gut barrier integrity, inflammatory status, and the gut-brain axis, given the relevance of these factors in the development of metabolic diseases.

Association of age at menopause with type 2 diabetes mellitus in postmenopausal women in the United States: National Health and Nutrition Examination Survey 2011-2018

Introduction

The present study aimed to examine the impact of age at menopause on the type 2 diabetes mellitus (T2DM) risk in postmenopausal women.

Material and methods

We included 4,968 postmenopausal women from the National Health and Nutrition Examination Survey 2011-2018. Age at menopause was measured by single year and categorically (< 40 years, 40-44 years, 45-54 years, 55 years and above). The outcome variable T2DM was measured with self-report and fasting blood glucose level. We performed logistic regression to estimate the odds ratio (OR) (95% confidence interval [CI]). Linear regression was used to examine the correlation between age at menopause and age at T2DM.

Results

Of the 4,968 postmenopausal women, 796 (16.0%) had T2DM after menopause. The mean age at menopause was 44.2 years. The mean age at T2DM was 57.2 years. Adjusting for potential confounders, the ORs for the association between age at menopause of < 40 years, 40-44 years and ≥ 55 years and T2DM were 1.97 (95% CI: 1.47-2.63), 1.27 (95% CI: 0.90-1.79) and 0.98 (95% CI: 0.66-1.45), respectively, compared to women having menopause at age 45 to 54 years. Each increase by 1 year in age at menopause was associated with a 3% reduction in the prevalence of T2DM (95% CI: 2-5). Age at menopause was significantly correlated with age at T2DM. Each 1-year increase in age at menopause might lead to a decrease of 0.39 years in age at T2DM.

Conclusions

Premature menopause was associated with increased T2DM risk in women. The earlier menopause occurs, the younger is the age at which T2DM may occur.